{"entity":{"type":"insider","cik":"0001722234","url":"/insider/0001722234","json_url":"/insider/0001722234.json","name":"Agger Mette Kirstine","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":3,"n_filings":3,"first":"2018-02-13","last":"2020-03-16","span_basis":"filed_date"},"name_variants":[{"name":"Agger Mette Kirstine","source":"filing","n_filings":3,"first_seen":"2018-02-13","last_seen":"2020-03-16"}],"transactions":[{"id":2541408,"accession":"0000899243-20-008492","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-008492","line_url":"/filing/0000899243-20-008492#line-2","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"IMARA Inc.","issuer_ticker":"IMRA","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001722234","owner_name":"Agger Mette Kirstine","owner_display_name":"Agger Mette Kirstine","owner_url":"/insider/0001722234","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":187500.0,"shares_display":"187,500","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":3000000.0,"total_display":"3,000,000.00","total_whole":"3,000,000","shares_owned_after":1432722.0,"shares_owned_after_display":"1,432,722","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-03-16","filed_date":"2020-03-16","scope":"insider"},{"id":7830770,"accession":"0000899243-19-013253","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-19-013253","line_url":"/filing/0000899243-19-013253#line-2","is_derivative":false,"issuer_cik":"0001563880","issuer_name":"Trevi Therapeutics, Inc.","issuer_ticker":"TRVI","issuer_name_source":null,"issuer_url":"/issuer/0001563880","owner_cik":"0001722234","owner_name":"Agger Mette Kirstine","owner_display_name":"Agger Mette Kirstine","owner_url":"/insider/0001722234","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":375000.0,"shares_display":"375,000","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":3750000.0,"total_display":"3,750,000.00","total_whole":"3,750,000","shares_owned_after":1151544.0,"shares_owned_after_display":"1,151,544","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-05-09","filed_date":"2019-05-13","scope":"insider"},{"id":9204555,"accession":"0000899243-18-003707","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-18-003707","line_url":"/filing/0000899243-18-003707#line-1","is_derivative":false,"issuer_cik":"0001722234","issuer_name":"scPharmaceuticals Inc.","issuer_ticker":"SCPH","issuer_name_source":null,"issuer_url":"/issuer/0001722234","owner_cik":"0001722234","owner_name":"Agger Mette Kirstine","owner_display_name":"Agger Mette Kirstine","owner_url":"/insider/0001722234","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":654762.0,"shares_display":"654,762","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":9166668.0,"total_display":"9,166,668.00","total_whole":"9,166,668","shares_owned_after":3183986.0,"shares_owned_after_display":"3,183,986","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-11-21","filed_date":"2018-02-13","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":3,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":3},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001672619","name":"IMARA Inc.","url":"/issuer/0001672619","role":"Director, Ten percent owner","n_filings":1,"first_seen":"2020-03-16","last_seen":"2020-03-16"},{"type":"issuer","type_label":"ISSUER","cik":"0001563880","name":"Trevi Therapeutics, Inc.","url":"/issuer/0001563880","role":"Director","n_filings":1,"first_seen":"2019-05-13","last_seen":"2019-05-13"},{"type":"issuer","type_label":"ISSUER","cik":"0001604950","name":"scPharmaceuticals Inc.","url":"/issuer/0001604950","role":"Director, Ten percent owner","n_filings":1,"first_seen":"2018-02-13","last_seen":"2018-02-13"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001722234","retrieved_at":"2026-08-26T09:25:26+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}